Recent Company News

• 04:08 AM ET May 20, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:16 AM ET Jul 29, 2025
  

  Renalytix services contract with Joslin diabetes Center and major Pharma partner (7.2500p, 0)

• 03:37 PM ET Jul 21, 2025
  

  MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities

• 02:08 AM ET Jul 17, 2025
  

  Renalytix, MVP Health Care enter partnership to mitigate progression of chronic kidney disease in their insured type 2 diabetes patient population (6.7500p, 0)

• 02:09 AM ET Jun 17, 2025
  

  Renalytix announces presentation of new pivotal data demonstrating how kidneyintelX.dkd enhances risk assessment over standard clinical measures alone during European Renal Association Congress 2025 (7.2500p, 0)

• 02:04 AM ET Jun 03, 2025
  

  Renalytix announces collaboration with New York Kidney & Hypertension Medicine to expand access to kidneyintelX.dkd (7.2500p, 0)

• 02:13 AM ET May 20, 2025
  

  Renalytix announces key milestone has been reached in very first use of KidneyIntelX in clinical trial (8.2500p, 0)